1020931

Ammar Hemaidan — FEI 3005234766

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 21, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Port Orange, FL (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance
756221 CFR 312.60Informed consent